Last week, IDL Diagnostics participated as an exhibitor at WHX Labs Dubai together with concile as part of the recently announced joint venture. The main focus is on delivering multiple biomarkers across different POC reader configurations and supporting infection, cardiac, oncology, hormones and chronic disease testing in a structured, platform-driven way.
IDL Diagnostics at Urology Week in Växjö
Last week, IDL Diagnostics participated in Urology Week 2026 in Växjö. The event brought together professionals from across the field of urology and offered a valuable opportunity to engage in discussions about current research, clinical perspectives and ongoing...
